We have published our first articles on the F1000 Research beta site and have already learned a lot about what works, what doesn’t quite, and what we need to consider as we move towards our full launch at the end of the year. Based on the experience of the past couple of weeks, we have…
Exciting things are kicking off here at F1000. At the start of this year, we announced our plans to develop a new project – F1000 Research – an attempt to create a new open access, open data publishing model within biology and medicine, with open and transparent peer review. Well, we’re pleased to announce that…
As I mentioned in one of my posts last week, we have devised a novel approach to article citation, in conjunction with our Advisory Panel and the major indexers, that will handle the complexities of citing articles that are in an evolving state of refereeing and may have more than one version – if they…
I am delighted to announce the publication of our first articles on our preliminary consultation site. They showcase a range of topics and all offer easy access to the data behind the results. HIV education campaigns in Africa leaving public vulnerable Devon Brewer (Director, Interdisciplinary Scientific Research) has submitted an article entitled Knowledge of specific…
We’re delighted to announce that F1000 Research and figshare have teamed up to build a widget for F1000 Research articles that enables users to preview, download, cite and share data in accompanying datasets, at the click of a button. You will be able to see this new tool for the first time in some of…
Sorry for the long silence since my last post – we’ve been busy getting everything ready! We’re in fact almost there now and will be publishing our first articles in the next few days. As we announced back in January, we expect to publish a small number of articles over the coming months so that…
We are delighted to welcome on board an exceptional list of some of the biggest names across biology and medicine onto our F1000 Research Advisory Panel. Over the past couple of weeks, our panel has doubled in size to over 200 members, and I am sure most of you will recognise many of these individuals.…
Many recent blogs and tweets have been suggesting F1000 Research as an alternative for those who have been using Nature Precedings, which closes today. We would be delighted to receive such submissions so if you do have something that you had planned to send to Nature Precedings within the fields of biology and medicine (or…
We’d like to start by welcoming Steven Hyman, Alan Schechter, Judith Kimble and Marvin Wickens to the F1000 Research Advisory Panel. Steven is Director of the Stanley Center for Psychiatric Research at the Broad Institute, and Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Alan is Chief of the Molecular Medicine Branch…
To start, we’d like to extend a warm welcome to Tim Clark, the newest member of our ever-growing Advisory Panel. Tim is the Director of Informatics at the MassGeneral Institute for Neurodegenerative Disease (MIND), and an Instructor in Neurology at Harvard Medical School. With over 22 years of experience within the bioinformatics field, Tim’s work…
